Bruker Valuation
| BRKR Stock | USD 56.88 2.13 3.61% |
At this time, the firm appears to be undervalued. Bruker shows a prevailing Real Value of $61.93 per share. The current price of the firm is $56.88. Our model approximates the value of Bruker from analyzing the firm fundamentals such as Profit Margin of 0.09 %, return on equity of 0.2, and Current Valuation of 10.89 B as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Bruker's valuation include:
Price Book 4.7719 | Enterprise Value | Enterprise Value Ebitda 18.2578 | Price Sales 2.7599 | Forward PE 22.779 |
Undervalued
Today
Please note that Bruker's price fluctuation is very steady at this time. Calculation of the real value of Bruker is based on 3 months time horizon. Increasing Bruker's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Bruker stock is determined by what a typical buyer is willing to pay for full or partial control of Bruker. Since Bruker is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Bruker Stock. However, Bruker's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 56.88 | Real 61.93 | Target 73.8 | Hype 56.95 |
The intrinsic value of Bruker's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Bruker's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Bruker helps investors to forecast how Bruker stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Bruker more accurately as focusing exclusively on Bruker's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Bruker's intrinsic value based on its ongoing forecasts of Bruker's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Bruker's closest peers.
Bruker Cash |
|
Bruker Valuation Trend
Bruker's real value is important for investors to make better decisions and a more accurate overall view of Bruker's financial worth over time. Using both Bruker's enterprise value as well as its market capitalization is the best way to gauge the value of the company and is usually enough for investors to make market timing conclusions.
Bruker Revenue by Product
Bruker Total Value Analysis
Bruker is currently forecasted to have valuation of 10.89 B with market capitalization of 8.95 B, debt of 1.38 B, and cash on hands of 733.6 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Bruker fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
10.89 B | 8.95 B | 1.38 B | 733.6 M |
Bruker Investor Information
About 32.0% of the company shares are held by company insiders. The book value of Bruker was currently reported as 11.92. The company last dividend was issued on the 2nd of December 2024. Based on the analysis of Bruker's profitability, liquidity, and operating efficiency, Bruker is performing exceptionally good at this time. It has a great probability to report excellent financial results in February.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Total Cash From Operating Activities | 422.7 M | 402.6 M |
|
|
Bruker Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Bruker has an asset utilization ratio of 69.75 percent. This connotes that the Company is making $0.7 for each dollar of assets. An increasing asset utilization means that Bruker is more efficient with each dollar of assets it utilizes for everyday operations.Bruker Ownership Allocation
Bruker holds a total of 151.6 Million outstanding shares. The majority of Bruker outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Bruker to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Bruker. Please pay attention to any change in the institutional holdings of Bruker as this could imply that something significant has changed or is about to change at the company. Also note that nearly eighteen million one hundred seventy-six thousand six hundred invesors are currently shorting Bruker expressing very little confidence in its future performance.Bruker Profitability Analysis
The company reported the previous year's revenue of 2.96 B. Net Income was 427.2 M with profit before overhead, payroll, taxes, and interest of 1.62 B.Bruker Past Distributions to stockholders
About Bruker Valuation
The stock valuation mechanism determines Bruker's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Bruker based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Bruker. We calculate exposure to Bruker's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Bruker's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 1.7 B | 1.8 B | |
| Pretax Profit Margin | 0.18 | 0.17 | |
| Operating Profit Margin | 0.13 | 0.07 | |
| Net Profit Margin | 0.13 | 0.14 | |
| Gross Profit Margin | 0.59 | 0.52 |
A single share of Bruker represents a small ownership stake in the entity. As a stockholder of Bruker, your percentage of company ownership is determined by dividing the number of shares you own by the total number of shares outstanding and then multiplying that amount by 100. Owning stock in a company generally confers both corporate voting rights and income from any dividends paid to the stock owner.
Bruker Dividends Analysis For Valuation
As of 01/19/2025, Dividends Paid is likely to drop to about 19.1 M. In addition to that, Dividend Yield is likely to drop to 0. At this time, Bruker's Retained Earnings are relatively stable compared to the past year. As of 01/19/2025, Retained Earnings Total Equity is likely to grow to about 2.3 B, while Price Earnings Ratio is likely to drop 27.51.
| Last Reported | Projected for Next Year | ||
| Dividends Paid | 33.8 M | 19.1 M | |
| Dividend Payout Ratio | 0.08 | 0.08 | |
| Dividend Paid And Capex Coverage Ratio | 2.31 | 2.23 |
There are various types of dividends Bruker can pay to its shareholders, and the actual value of the dividend is determined on a per-share basis. It is to be paid equally to all of Bruker shareholders on a specific date, known as the payable date. The cash dividend is the most common type of dividend payment - it is the payment of actual cash from Bruker directly to its shareholders. There are other types of dividends that companies can issue, such as stock dividends or asset dividends. When Bruker pays a dividend, it has no impact on its enterprise value. It does, however, lowers the Equity Value of Bruker by the value of the dividends paid out.
Bruker Growth Indicators
Investing in growth stocks can be very risky. If the company such as Bruker does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 147.2 M | |
| Quarterly Earnings Growth Y O Y | -0.55 | |
| Forward Price Earnings | 22.779 |
Bruker Current Valuation Indicators
Bruker's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Bruker's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Bruker, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Bruker's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Bruker's worth.Additional Tools for Bruker Stock Analysis
When running Bruker's price analysis, check to measure Bruker's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bruker is operating at the current time. Most of Bruker's value examination focuses on studying past and present price action to predict the probability of Bruker's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bruker's price. Additionally, you may evaluate how the addition of Bruker to your portfolios can decrease your overall portfolio volatility.